Butyrolactone I
-
Aspergilli, a large and diverse genus of ubiquitous filamentous fungi are the source of diverse secondary metabolites that can be used in the development of medications to treat diseases. Butyrolactone I is produced as a secondary metabolite by A. terreus. Butyrolactone I is a potent inhibitor of the eukaryotic cyclin-dependent kinases (CDK’s), protein kinases which control cell progression in all eukaryotes. Cyclin-dependent kinases are involved in numerous diseases in human beings like, cancer, stroke, diabetes, inflammation and AIDS.
11p kethamoi2 15-12-2019 15 1 Download